Shareholders meeting

Kilitch Drugs (India) Ltd. KI 27" August, 2026 To, To, The Manager - Corporate Relationship The Manager - Corporate Compliance Dept. National Stock Exchange of India Ltd BSE Limited Exchange Plaza, Plot No.C-1, P. J. Towers, Dalal Street G Block, BKC, Bandra (E), Fort, Mumbai - 400 001 Mumbai 400 051 Scrip Code: BSE - 524500 Scrip Code: NSE - KILITCH Sub: Proceedings and Outcome of the 34 Annual General Meeting of the Company held today i.e. Thursday, 27 August, 2026. Dear Sir, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the 34 Annual General Meeting (“AGM”) of the Company was held today i.e. Thursday, 27" August, 2026 through video conferencing. We are enclosing herewith the summery of the proceeding of the AGM for your record. The details of the voting results along with the Scrutinizer’s Report will be disseminated to the Stock Exchanges and will be placed on the Company’s website, 1n due course. The meeting was commenced at 9:00 a.m. and concluded at 9:51 a.m. Kindly take the same on record and acknowledge the receipt. Thanking you, For Kilitch Drugs (India) Limited Mukund Mehta Managing Director Ny == 139408051::22000038 WHO CEe RTIFIED ”veR ono. Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. « Tel.: +91-22-6121 4100 « Fax : +91-22-6703 1658 Registered Office & Manufacturing unit : C-301/2, M.1.D.C., T.T.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra. « CIN: L24239MH1992PLC066718 « Tel.: +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail : info@kilitch.com « Website : www.kilitch.com Kilitch Drugs (India) Ltd. KI Proceedings of 34 Annual General Meeting of the Company held on Thursday, 27" August, 2026 The 34 Annual General Meeting (“AGM”) of the Members of Kilitch Drugs (India) Limited was held today i.e. Thursday, 27 August, 2026 at 9:00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) only. The meeting was held in compliance with the applicable provisions of the Companies Act, 2013 read with the circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India without physical presence of the members. Mr. Mukund Mehta, Managing Director, Mrs. Mira Mehta, Managing Director, Mr. Bhavin Mehta, Whole-time Director, Prof. Vasudev Krishna Murti, Independent Director, Mr. Dipen Jain, Independent Director, Mr. Venkita Subramanian Rajan, Independent Director, Mr. Sunil Jain, Chief Financial Officer, Ms. Pushpa Nyoupane, Company Secretary, Mr. Chintan Shah, Proprietor of C Sharat and Associates Statutory Auditors, Mr. Deep Shukla, the Proprietor of Deep Shukla & Associates, Secretarial Auditors and Scrutinizer of the meeting and Mr. Arvind Kumar, Proprietor of Arvind Kumar and Co. Cost Auditors of the Company had joined the meeting. Participants’ details: Member attended: Members [Promoter and Promoter Group - 3 and Public - 50] Mr. Mukund Mehta, Managing Director chaired the meeting and since the requisite quorum was present, the meeting was called to order. Ms. Pushpa Nyoupane, Company Secretary of the Company commenced the meeting by welcoming all attendees and briefing the general instructions regarding the participation in the meeting through video conferencing and remote e-voting as well as voting during the meeting electronically to the members. With the permission of Chairman, the Company Secretary introduced all the panelist with the shareholders. The Company Secretary informed that all efforts feasible under the circumstances have indeed been made by the Company to enable members to participate and vote on the item being considered in the meeting electronically. The Company Secretary also informed that pursuant to the guidelines and circulars issued by the Ministry of Corporate Affairs and SEBI Listing Regulations, the facility to appoint proxy by members to attend the meeting and cast vote was not applicable for 34° AGM as the AGM was convened through VC /OAVM. Mr. Mukund Mehta addressed the member on performance and business prospect of the Company. With the permission of members, the Notice convening the 34 AGM, Director's Report, Audited Standalone and Consolidated Financial Statements for the Financial Year ended 31*' March, 2026 and Auditors' Report thereon which was sent through electronic mode to the Members of the Company was taken as read. (FsESo @fa)e ee rete ie ‘ P , Se INDIA ‘34352008 WHO CERTIFIED Parsee wai Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. « Tel.: +91-22-6121 4100 « Fax : +91-22-6703 1658 Registered Office & Manufacturing unit : C-301/2, M.1.D.C., T.T.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra. « CIN: L24239MH1992PLC066718 « Tel.: +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail : info@kilitch.com « Website : www.kilitch.com Kilitch Drugs (India) Ltd. KI The following items of business, as per the Notice convening the 34° AGM of the Company, were transacted at the meeting: Resolution No. 1 - To receive, consider, approve and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the year ended 31*t March, 2026, together with the Report of the Board of Directors and Auditors thereon; as ordinary resolution Resolution No. 2 - To re- appoint Mr. Mukund Mehta (DIN: 00147876) as a director who retires by rotation and being eligible, offers himself for re-appointment, as ordinary resolution Resolution No. 3 - To approve the payment of performance linked pay (PLI) to executive directors; as Special Resolution Resolution No. 4 - To ratify the remuneration to the Cost Auditor of the Company; as ordinary resolution Thereafter, Speaker shareholders were allowed to speak at the meeting to ask their queries. After responding to the speaker shareholders queries, the meeting was concluded at 9:51 a.m. with the vote of thanks. The e-voting facility was made available to the members for 15 minutes post conclusion of the meeting. Please note that the results of the voting will be separately informed to the exchanges For Kilitch Drugs (India) Limited Mukund Mehta Managing Director DIN: 00147876 do @) iFsERo | 6t@as) ono. 12991:30¢8 = WHO aCER TIFIED Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. e Tel.: +91-22-6121 4100 « Fax : +91-22-6703 1658 Registered Office & Manufacturing unit : C-301/2, M.1.D.C., T.T.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra. « GIN: L24239MH1992PLC066718 « Tel.; +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail : info@kilitch.com « Website : www.kilitch.com